|Videos|September 22, 2017
What is Castration-Resistant Prostate Cancer?
Advertisement
Episodes in this series
Advertisement
Related to this article
Longer follow-up of the phase 2 LUNAR trial showed a 62% lower risk of progression, additional hormone therapy or death with 177Lu-PNT2002 plus radiation.
A rising PSA after surgery or radiation can be frightening. Learn what biochemical recurrence means, which tests come next and your treatment options.
A Phoenix man with metastatic castration-sensitive prostate cancer shares how back pain led to a PSA test and how his family helped him cope.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
2
Diagnosed With Sarcoma at 21, She Found Her People at Mary's Place
3
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
4
Stage 4 Breast Cancer: How a Second Opinion Saved Her Life
5